Climate Change Data Portal
DOI | 10.1073/pnas.2020401118 |
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3 | |
Qiu M.; Glass Z.; Chen J.; Haas M.; Jin X.; Zhao X.; Rui X.; Ye Z.; Li Y.; Zhang F.; Xu Q. | |
发表日期 | 2021 |
ISSN | 00278424 |
卷号 | 118期号:10 |
英文摘要 | Loss-of-function mutations in Angiopoietin-like 3 (Angptl3) are associated with lowered blood lipid levels, making Angptl3 an attractive therapeutic target for the treatment of human lipoprotein metabolism disorders. In this study, we developed a lipid nanoparticle delivery platform carrying Cas9 messenger RNA (mRNA) and guide RNA for CRISPR-Cas9–based genome editing of Angptl3 in vivo. This system mediated specific and efficient Angptl3 gene knockdown in the liver of wild-type C57BL/6 mice, resulting in profound reductions in serum ANGPTL3 protein, low density lipoprotein cholesterol, and triglyceride levels. Our delivery platform is significantly more efficient than the FDA-approved MC-3 LNP, the current gold standard. No evidence of off-target mutagenesis was detected at any of the nine top-predicted sites, and no evidence of toxicity was detected in the liver. Importantly, the therapeutic effect of genome editing was stable for at least 100 d after a single dose administration. This study highlights the potential of LNP-mediated delivery as a specific, effective, and safe platform for Cas9-based therapeutics. © 2021 National Academy of Sciences. All rights reserved. |
英文关键词 | Angptl3; CRISPR-Cas9 mRNA delivery; Genome editing; Lipid nanoparticles |
语种 | 英语 |
来源期刊 | Proceedings of the National Academy of Sciences of the United States of America
![]() |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/180406 |
作者单位 | Department of Biomedical Engineering, Tufts University, Medford, MA 02155, United States; Broad Institute of MIT and Harvard, Cambridge, MA 02142, United States |
推荐引用方式 GB/T 7714 | Qiu M.,Glass Z.,Chen J.,et al. Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3[J],2021,118(10). |
APA | Qiu M..,Glass Z..,Chen J..,Haas M..,Jin X..,...&Xu Q..(2021).Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3.Proceedings of the National Academy of Sciences of the United States of America,118(10). |
MLA | Qiu M.,et al."Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3".Proceedings of the National Academy of Sciences of the United States of America 118.10(2021). |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[Qiu M.]的文章 |
[Glass Z.]的文章 |
[Chen J.]的文章 |
百度学术 |
百度学术中相似的文章 |
[Qiu M.]的文章 |
[Glass Z.]的文章 |
[Chen J.]的文章 |
必应学术 |
必应学术中相似的文章 |
[Qiu M.]的文章 |
[Glass Z.]的文章 |
[Chen J.]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。